
About RefleXion
RefleXion is a Healthcare company based in Hayward (United States) founded in 2009 by Samuel Mazin. Biology-guided radiotherapy systems are provided for cancer treatment. RefleXion has raised $553.91 million across 18 funding rounds from investors including Pfizer, Johnson & Johnson and T. Rowe Price. Its chief executive, as recorded, is Todd Powell. Its website reflexion.com draws about 11 thousand monthly visits. RefleXion offers products and services including SCINTIX Therapy and RefleXion X1. Its focus areas include Life Sciences, Oncology, Medical Devices and Therapies. Its legal entity is REFLEXION MEDICAL. Its competitors include Mevion Medical Systems, ZAP-X and Nanospectra; 3 of its 3 listed competitors have raised funding.
Company details
RefleXion was founded in 2009 and is headquartered in Hayward, United States. The company operates in the medical technology sector, focusing on radiotherapy solutions. Its technology integrates Positron Emission Tomography to enable real-time tumor tracking and personalized radiation delivery. Applications target lung, prostate, and breast cancers, supporting precise treatment processes in oncology care.
- Total Equity Funding$553.91M (USD)
in 18 rounds
- Latest Funding Round$106.71M (USD), Series F
Nov 2023
- InvestorsPfizer
& 20 more
Products & Services of RefleXion
RefleXion offers a comprehensive portfolio of products and services, including SCINTIX Therapy and RefleXion X1.
Utilizes cancer emissions for real-time tumor tracking and treatment.
Combines PET imaging with radiotherapy to target moving tumors.
Apps and channels of RefleXion
its YouTube channel RefleXion Medical has 352 subscribers and 23 videos.
Videos from RefleXion
The most watched videos on RefleXion's YouTube channel, RefleXion Medical (352 subscribers). Click a video to play it here.
More on RefleXion Medical.
Funding Insights of RefleXion
RefleXion has successfully raised a total of $553.91M across 18 strategic funding rounds. The most recent funding activity was a Series F round of $106.71 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $553.91M
- Total Rounds 18
- Last Round Series F β $106.71M
- First Round $1.5M
(Jul 2010)
- Investors Count 21
Latest 10 of 18 funding rounds of RefleXion with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2023 | $106.71M | Series F | β | The Rise Fund | |
| Jul 2022 | $125M | Debt – Conventional | β | β | |
| Mar 2022 | $80M | Series E | β | Ascension, Catalio Capital Management | |
| Mar 2021 | $40M | Series D | β | β | |
| Apr 2020 | $100M | Series D | β | PSP Investments | |
| May 2019 | $60M | Debt – Conventional | β | β | |
| Apr 2018 | $2.3M | Grant | β | β | |
| Mar 2018 | $100M | Series C | β | The Rise Fund | |
| Jul 2016 | $52M | Series B | β | β | β |
| Apr 2016 | $52M | Series B | β | KCK MedTech |
21 investors in total: 21 institutional.
Investors in RefleXion
RefleXion has secured backing from 21 investors, including venture fund and institutional investors. Prominent investors backing the company include Pfizer, Johnson & Johnson and T. Rowe Price.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Sector-agnostic VC investment company investing globally | therisefund.com | San Francisco, United States | ||
Private equity and hedge fund investments in healthcare are managed. | ally-bridge.com | Hong Kong, China | ||
Venture capital firm focused on tech sectors | venrock.com | Palo Alto, United States | ||
Venture capital is provided to biomedical technology startups. | cataliocapital.com | New York, United States | ||
Venture debt firm focused on the life sciences sector | 2002 | oxfordfinance.com | Alexandria, United States | |
Ascension is recognized as a venture capital firm focused on early-stage tech investments. | ascension.vc | London, United Kingdom | ||
Venture capital fund focused on tech startups | sixtydegreecapital.com | North York, Canada | ||
Venture capital firm backed by Johnson & Johnson | jnjinnovation.com/jjdc | Cambridge, United States | ||
Sofinnova Partners is focused on life sciences and healthcare investments. | sofinnovapartners.com | Paris, France |
Investor details for RefleXion
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of RefleXion
68 people are tracked at RefleXion (30 in leadership, 18 in board & advisors, 20 in team).
| Name | Role | Group |
|---|---|---|
Samuel Mazin | Co-Founder & CTO | Leadership |
Todd Powell | CEO & President | Leadership |
Shiyu Xu | Senior Managing Principal Algorithm Enginer | Leadership |
Judy Bartlett-Roberto | VP, Marketing | Leadership |
Atul Nayak | Sr. Director, External Innovation - Strategy & Operations | Leadership |
Jeff Holifield | Vice President & Head of Legal | Leadership |
Leonard Lyons | VP, Sales | Leadership |
Philip J. Aulson II | Senior Vice President of Operations and Service | Leadership |
Sukh Sandher | Sr. Director Of Quality Engineering | Leadership |
Shervin 'Sean' Shirvani | CMO | Leadership |
Aaron Sass | Director Of Sales | Leadership |
Jermaine Cuyler | Director Of Sales - East Coast | Leadership |
Elise Govek Sphr, Phr-Ca | Human Resources Director | Leadership |
Karine A. al Feghali M.D., Msc | Senior Medical Director, Medical Affairs | Leadership |
Jay Janardhanan | Vice President Software Engineering | Leadership |
James Zug | Director Of Software Applications | Leadership |
Hector Ruiz de Vinaspre | Director Of Sales | Leadership |
Arjun Maniyedath | Vice President, Scientific & Medical Programs | Leadership |
Sean Shirvani M.D. Mph | Chief Medical Officer | Leadership |
Jason McCurry | Chief Information Security Officer, Senior Director Of IT | Leadership |
48 more people are available in the full profile.
Complete people profiles for RefleXion
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of RefleXion
3 dated milestones of RefleXion across 14 years, from founding to its latest funding, stage changes and deals.
- Founded RefleXion is founded.
- Funding First funding round of $1.5M.
- Funding Latest funding round, Series F, of $106.7M.
Competitors of RefleXion
RefleXion has 3 listed competitors in our database, 3 of them funded. They include Mevion Medical Systems, ZAP-X and Nanospectra.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mevion.com | 2004 | Littleton, United States | $500.18M | 136 | Proton therapy systems are supplied for cancer radiation treatment. | |
| zapsurgical.com | 2014 | San Carlos, United States | $159M | Developer of gyroscopic radiosurgery platform | ||
| nanospectra.com | 2002 | Houston, United States | $24.52M | 9 | Nanoparticle-based therapies for solid tumor treatment are developed. |
Detailed competitors of RefleXion
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of RefleXion
The website of RefleXion (reflexion.com) receives about 10.8K visits a month.
- Monthly visits10.8K
▲ 12.1% vs previous month
Top companies in Oncology
3 companies that operate in the same segment as RefleXion (Oncology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Reflexion
Complete news archive for RefleXion
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RefleXion
RefleXion was founded in 2009 and raised its 1st funding round 1 year after it was founded.
RefleXion is headquartered in Hayward, United States. It is registered at Hayward, California, United States.
Todd Powell is the CEO of RefleXion, as recorded in our data.
RefleXion is a funded company, having raised a total of $553.91M across 18 funding rounds to date. The company's 1st funding round was a Series B of $52M, raised on Jul 2010.
RefleXion was founded in 2009 and is headquartered in Hayward, United States. The company operates in the medical technology sector, focusing on radiotherapy solutions. Its technology integrates Positron Emission Tomography to enable real-time tumor tracking and personalized radiation delivery. Applications target lung, prostate, and breast cancers, supporting precise treatment processes in oncology care.
RefleXion's top competitors include ZAP-X, Mevion Medical Systems and Nanospectra.
RefleXion offers SCINTIX Therapy and RefleXion X1.
RefleXion has 21 investors. Key investors include Pfizer, Johnson & Johnson, T. Rowe Price, HHS, and Hillenbrand.
RefleXion operates through Reflexion Medical.
